TRACY HUTCHINSON: Open Payments
NPI 1265161400 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,623 in 94 payments from 14 companies in 2025. Trend: 2023 $800 · 2024 $1,966 · 2025 $1,623
Food & beverage: $1,509Education: $114
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $262 |
| Amgen Inc. | 19 | $207 |
| PFIZER INC. | 14 | $190 |
| AstraZeneca Pharmaceuticals LP | 9 | $171 |
| UCB, Inc. | 8 | $164 |
| GlaxoSmithKline, LLC. | 9 | $164 |
| ABBVIE INC. | 10 | $155 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
Products named: TREMFYA, XELJANZ, Bimzelx, BENLYSTA, SAPHNELO, RINVOQ, ORENCIA, COSENTYX.
Industry payments across KY — which companies pay providers there.
